Preparation of bone marrow mesenchymal stem cells expressing hVEGF121/EGFP fusion protein and hypoxia intervertion

Yao-sheng Wang,Ling Wang,Ren-qiang Yang,Xiao-shu Cheng
DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.21.013
2008-01-01
Abstract:Aim: To construct human vascular endothelial growth factor121 (hVEGF121) eukaryotic plasmid that contains enhanced green fluorescent protein (EGFP) report gene, and to investigate the VEGF expression of hVEGF121/EGFP-expressing bone marrow mesenchymal stem cells (BMSCs) after different time courses of hypoxic culture. Methods: We designed the total length amplification primer of hVEGF121 with restriction endonuclease cutting sites, amplified the coding fragment of hVEGF121 by polymerase chain reaction (PCR), ligated the hVEGF121 coding fragment directly into multiple clone site (MCS) of pEGFP-N2 by sticky ends ligating clone method. Then, the recombinant plasmid-pEGFP-N2-hVEGF121 was constructed. Recombinant was identified by digestion, PCR, DNA sequencing technology. BMSCs were isolated by whole bone marrow differential attachment method, and then in vitro passaged several times. Cells were identified according to morphology and surface markers analysis. BMSCs were transfected with pEGFP-N2-hVEGF121 by positive ionic liposome transfection method. Under fluorescent microscope, the expression of hVEGF121/EGFP fusion protein was detected. The hVEGF121/EGFP-expressing BMSCs were cultured under hypoxic condition for 6, 12, 24 hours. Control group was blank BMSCs and BMSCs transfected with blank vector-pEGFP-N2 under the same hypoxic intervention. The VEGF mRNA expression of each group was detected by reserve transcription (RT)-PCR method. Results: Digestion, PCR and DNA sequencing completely confirmed that we constructed the plasmid pEGFP-N2-hVEGF121 successfully. The BMSCs, which transfected with pEGFP-N2- hVEGF121, was observed under the fluorescent microscope. After 6, 12 24 hours' hypoxic culture which mimic the microenvironment of myocardial hypoxia in vitro, RT-PCR results showed that recombinant transfected BMSCs expressed higher levels of VEGF mRNA than control group (P < 0.01) after each time course of hypoxic culture, and there was no statistic differences among each time course (P > 0.05). The VEGF mRNA expression of control group was upgrading along with the prolongation of the hypoxic culture time. Conclusion: This study successfully constructed human VEGF121/ EGFP fusion protein expressed in BMSCs. Confirmed that hVEGF121/EGFP fusion protein-expressing BMSCs can endure adequate time of hypoxic environment in 24 hours, and sustain stronger and more stable VEGF expression.
What problem does this paper attempt to address?